Department of International Health, Johns Hopkins Bloomberg School of Public Health, 415 N Washington Street, Baltimore, MD, 21205, USA.
Jhpiego Kenya, 2nd Floor, Arlington Block, 12 Riverside, Off Riverside Drive, P.O. Box 66119-00800, Nairobi, Kenya.
Matern Child Health J. 2024 Oct;28(10):1822-1832. doi: 10.1007/s10995-024-03982-8. Epub 2024 Aug 14.
Respiratory syncytial virus (RSV) is a leading cause of respiratory illness in infants globally, with new maternal RSV vaccines on the horizon. Vaccine decision-making during pregnancy is shaped by individual, interpersonal, community, and societal factors. This study explored key interpersonal influences on maternal vaccine decision-making among pregnant and lactating people (PLP) and community members in Kenya.
This qualitative study conducted in-depth interviews with six pregnant people, 18 lactating people, and 10 community members in one rural and one urban county in Kenya. Data were analyzed using a grounded theory approach.
Participants identified the pregnant person themself, male partners, other family members, peers, and healthcare providers (HCPs) as key influences on the maternal immunization decision-making process. The majority of interviewed PLP believed that decision-making during pregnancy should be left to themselves due to autonomy and their role as the primary caregiver. Community members, including male partners, also identified pregnant people as the key decision-maker. While some PLP said they deferred to male partners to make vaccine decisions, more felt that men were not as informed on maternal and child issues as themselves or other female peers and relatives. HCPs emerged as important influences and information sources for PLP during decision-making.
Understanding who influences vaccine-decision making during pregnancy will help inform demand generation strategies, and in turn, uptake of future maternal vaccines, including RSV vaccines. Given the strong role HCPs and peers have in the decision-making process, targeting key potential influences is essential to improve vaccine acceptance.
呼吸道合胞病毒（RSV）是全球婴儿呼吸道疾病的主要病因，新的母体 RSV 疫苗即将问世。在怀孕期间进行疫苗决策受到个人、人际、社区和社会因素的影响。本研究旨在探索肯尼亚孕妇和哺乳期妇女（PLP）及社区成员中影响母体疫苗决策的关键人际因素。
本定性研究对肯尼亚一个农村县和一个城市县的 6 名孕妇、18 名哺乳期妇女和 10 名社区成员进行了深入访谈。采用扎根理论方法进行数据分析。
参与者确定孕妇本人、男性伴侣、其他家庭成员、同龄人以及医疗保健提供者（HCP）是影响母体免疫决策过程的关键因素。大多数接受采访的 PLP 认为，由于自主权和作为主要照顾者的角色，怀孕期间的决策应该由自己做出。社区成员，包括男性伴侣，也将孕妇视为关键决策者。虽然一些 PLP 表示他们听从男性伴侣做出疫苗决策，但更多人认为男性在孕产妇和儿童问题上的知识不如他们自己或其他女性同龄人或亲属丰富。HCP 是 PLP 在决策过程中的重要影响因素和信息来源。
了解谁在怀孕期间影响疫苗决策将有助于制定需求产生策略，从而提高未来母体疫苗（包括 RSV 疫苗）的接种率。鉴于 HCP 和同龄人在决策过程中发挥着重要作用，针对关键潜在影响因素至关重要，以提高疫苗的接受度。
